The challenge of viral reservoirs in HIV-1 infection

被引:488
作者
Blankson, JN [1 ]
Persaud, D
Siliciano, RF
机构
[1] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA
来源
ANNUAL REVIEW OF MEDICINE | 2002年 / 53卷
关键词
AIDS; latency; HAART; sanctuary; persistence;
D O I
10.1146/annurev.med.53.082901.104024
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
A viral reservoir is a cell type or anaton-deal site in association with which a replication-competent form of the virus accumulates and persists with more stable kinetic properties than the main pool of actively replicating virus. This article reviews several cell types and anatomical sites proposed as potential reservoirs for HIV-1. It is now clear that HIV-1 persists in a small reservoir of latently infected resting memory CD4+ T cells, which shows minimal decay even in patients on highly active antiretroviral therapy (HAART). The persistence of virus in this reservoir is consistent with the biology of these cells and the long-term persistence of immunologic memory. The viral replication that continues in patients on suppressive HAART may also contribute to the stability of this reservoir. There may be other reservoirs, but the latent reservoir in resting CD4+ T cells appears to be sufficient to guarantee lifetime persistence of HIV-1 in the majority of patients on current HAART regimens, and unless new approaches are developed, eradication will not be possible. The clinical implications of this and other HIV-1 reservoirs are discussed.
引用
收藏
页码:557 / 593
页数:37
相关论文
共 207 条
[11]   Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy [J].
Brinkman, K ;
Smeitink, JA ;
Romijn, JA ;
Reiss, P .
LANCET, 1999, 354 (9184) :1112-1115
[12]   Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination therapy [J].
Brodt, HR ;
Kamps, BS ;
Gute, P ;
Knupp, B ;
Staszewski, S ;
Helm, EB .
AIDS, 1997, 11 (14) :1731-1738
[13]   Generation of HIV latency during thymopoiesis [J].
Brooks, DG ;
Kitchen, SG ;
Kitchen, CMR ;
Scripture-Adams, DD ;
Zack, JA .
NATURE MEDICINE, 2001, 7 (04) :459-464
[14]  
Bruggeman LA, 2000, J AM SOC NEPHROL, V11, P2079, DOI 10.1681/ASN.V11112079
[15]   QUIESCENT LYMPHOCYTES-T AS AN INDUCIBLE VIRUS RESERVOIR IN HIV-1 INFECTION [J].
BUKRINSKY, MI ;
STANWICK, TL ;
DEMPSEY, MP ;
STEVENSON, M .
SCIENCE, 1991, 254 (5030) :423-427
[16]   ACTIVE NUCLEAR IMPORT OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PREINTEGRATION COMPLEXES [J].
BUKRINSKY, MI ;
SHAROVA, N ;
DEMPSEY, MP ;
STANWICK, TL ;
BUKRINSKAYA, AG ;
HAGGERTY, S ;
STEVENSON, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (14) :6580-6584
[17]   Follicular dendritic cells (FDC) in retroviral infection: Host/pathogen perspectives [J].
Burton, GF ;
Masuda, A ;
Heath, SL ;
Smith, BA ;
Tew, JG ;
Szakal, AK .
IMMUNOLOGICAL REVIEWS, 1997, 156 :185-197
[18]   HIV-1 in semen: an isolated virus reservoir [J].
Byrn, RA ;
Zhang, DZ ;
Eyre, R ;
McGowan, K ;
Kiessling, AA .
LANCET, 1997, 350 (9085) :1141-1141
[19]   DENDRITIC CELLS EXPOSED TO HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TRANSMIT A VIGOROUS CYTOPATHIC INFECTION TO CD4+ T-CELLS [J].
CAMERON, PU ;
FREUDENTHAL, PS ;
BARKER, JM ;
GEZELTER, S ;
INABA, K ;
STEINMAN, RM .
SCIENCE, 1992, 257 (5068) :383-386
[20]   Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance [J].
Carr, A ;
Samaras, K ;
Chisholm, DJ ;
Cooper, DA .
LANCET, 1998, 351 (9119) :1881-1883